The price of Geron Corp (NASDAQ:GERN) shares last traded on Wall Street fell -2.68% to $1.45.
GERN stock price is now 1.51% away from the 50-day moving average and -53.10% away from the 200-day moving average. The market capitalization of the company currently stands at $923.53M.
With the price target maintained at $1.50, Scotiabank recently Downgraded its rating from Sector Outperform to Sector Perform for Geron Corp (NASDAQ: GERN). On February 27, 2025, B. Riley Securities Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $3.50 to quote $2, while ‘H.C. Wainwright’ rates the stock as ‘Neutral’
In other news, LAWLIS V BRYAN, Director bought 13,300 shares of the company’s stock on May 09 ’25. The stock was bought for $15,667 at an average price of $1.18. Upon completion of the transaction, the Director now directly owns 13,300 shares in the company, valued at $19285.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 27 ’25, EVP, Chief Legal Officer Samuels Scott Alan bought 15,000 shares of the business’s stock. A total of $24,150 was incurred on buying the stock at an average price of $1.61. This leaves the insider owning 26,682 shares of the company worth $38688.9. A total of 5.26% of the company’s stock is owned by insiders.
During the past 12 months, Geron Corp has had a low of $1.17 and a high of $5.34. As of last week, the company has a debt-to-equity ratio of 0.92, a current ratio of 7.87, and a quick ratio of 6.97.
The net profit margin was -119.54% and return on equity was -45.35% for GERN. The company reported revenue of $39.6 million for the quarter, compared to $0.3 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 12927.3 percent.
